Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Pastorino

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Biomedicines|May 28, 2022
Editorial of the Special Issue "Targeted Therapies for Cancer"Fabio Pastorino, Chiara Brignole
Molecules (Basel, Switzerland)|September 15, 2020
Special Issue "Recent Advances in Precision Nanomedicine for Cancer"Chiara Brignole, Fabio Pastorino
Proteomics. Clinical Applications|January 10, 2017
Molecular galactose-galectin association in neuroblastoma cells: An unconventional tool for qualitative/quantitative screeningFabio Pastorino, Mirco Ponzoni, Giuseppina Simone
Animal : an International Journal of Animal Bioscience|October 4, 2023
Review: Impact of bilateral trade on the promotion of animal welfare rules. The case of trade relations between the European Union and MercosurLeonardo Fabio Pastorino, Washington Carlos de Almeida
International Journal of Molecular Sciences|July 6, 2018
Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and CancerMirco Ponzoni, Fabio Pastorino, Daniela Di Paolo, et al.
Medicinal Research Reviews|February 3, 2011
Targeted drug delivery and penetration into solid tumorsAngelo Corti, Fabio Pastorino, Flavio Curnis, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 2, 2008
Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicinFabio Pastorino, Davis R Mumbengegwi, Domenico Ribatti, et al.
Cancer Letters|July 26, 2003
Development of Fab' fragments of anti-GD(2) immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastomaChiara Brignole, Danilo Marimpietri, Claudio Gambini, et al.
Oncotarget|January 18, 2012
Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomasSandra Cantilena, Fabio Pastorino, Annalisa Pezzolo, et al.
Annals of the New York Academy of Sciences|January 15, 2005
Angiogenesis in neuroblastomaDomenico Ribatti, Danilo Marimpietri, Fabio Pastorino, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Biomedicines|May 28, 2022
Editorial of the Special Issue "Targeted Therapies for Cancer"Fabio Pastorino, Chiara Brignole
Molecules (Basel, Switzerland)|September 15, 2020
Special Issue "Recent Advances in Precision Nanomedicine for Cancer"Chiara Brignole, Fabio Pastorino
Proteomics. Clinical Applications|January 10, 2017
Molecular galactose-galectin association in neuroblastoma cells: An unconventional tool for qualitative/quantitative screeningFabio Pastorino, Mirco Ponzoni, Giuseppina Simone
Animal : an International Journal of Animal Bioscience|October 4, 2023
Review: Impact of bilateral trade on the promotion of animal welfare rules. The case of trade relations between the European Union and MercosurLeonardo Fabio Pastorino, Washington Carlos de Almeida
International Journal of Molecular Sciences|July 6, 2018
Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and CancerMirco Ponzoni, Fabio Pastorino, Daniela Di Paolo, et al.
Medicinal Research Reviews|February 3, 2011
Targeted drug delivery and penetration into solid tumorsAngelo Corti, Fabio Pastorino, Flavio Curnis, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 2, 2008
Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicinFabio Pastorino, Davis R Mumbengegwi, Domenico Ribatti, et al.
Cancer Letters|July 26, 2003
Development of Fab' fragments of anti-GD(2) immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastomaChiara Brignole, Danilo Marimpietri, Claudio Gambini, et al.
Oncotarget|January 18, 2012
Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomasSandra Cantilena, Fabio Pastorino, Annalisa Pezzolo, et al.
Annals of the New York Academy of Sciences|January 15, 2005
Angiogenesis in neuroblastomaDomenico Ribatti, Danilo Marimpietri, Fabio Pastorino, et al.
Pageof 9